Cost-Effectiveness Analysis of Continuous-Flow Left Ventricular Assist Devices as Destination Therapy
Joseph G. Rogers(Baylor College of Medicine), Mark S. Slaughter(University of Louisville), R.M. Adamson(University of Louisville), Robin Bostic(University of Louisville), Mark J. Russo(Rutgers, The State University of New Jersey), K. Tong(University of Louisville)
Cited by 156
Related Papers
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2020|832
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711